These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 17906021

  • 1. Follow-up of children exposed in utero to 17 alpha-hydroxyprogesterone caproate compared with placebo.
    Northen AT, Norman GS, Anderson K, Moseley L, Divito M, Cotroneo M, Swain M, Bousleiman S, Johnson F, Dorman K, Milluzzi C, Tillinghast JA, Kerr M, Mallett G, Thom E, Pagliaro S, Anderson GD, National Institute of Child Health and Human Development (NICHD) Maternal-Fetal Medicine Units (MFMU) Network.
    Obstet Gynecol; 2007 Oct; 110(4):865-72. PubMed ID: 17906021
    [Abstract] [Full Text] [Related]

  • 2. Association of 17α-Hydroxyprogesterone Caproate and Risk of Infection.
    Mainiero AD, Rouse DJ, Lopes V, Hughes BL.
    Obstet Gynecol; 2015 Jul; 126(1):103-8. PubMed ID: 26241262
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Congenital malformations among offspring exposed in utero to progestins, Olmsted County, Minnesota, 1936-1974.
    Resseguie LJ, Hick JF, Bruen JA, Noller KL, O'Fallon WM, Kurland LT.
    Fertil Steril; 1985 Apr; 43(4):514-9. PubMed ID: 3987922
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The effect of 17-alpha hydroxyprogesterone caproate on the risk of gestational diabetes in singleton or twin pregnancies.
    Gyamfi C, Horton AL, Momirova V, Rouse DJ, Caritis SN, Peaceman AM, Sciscione A, Meis PJ, Spong CY, Dombrowski M, Sibai B, Varner MW, Iams JD, Mercer BM, Carpenter MW, Lo J, Ramin SM, O'Sullivan MJ, Miodovnik M, Conway D, Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network.
    Am J Obstet Gynecol; 2009 Oct; 201(4):392.e1-5. PubMed ID: 19716543
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. In utero exposure to 17α-hydroxyprogesterone caproate and risk of cancer in offspring.
    Murphy CC, Cirillo PM, Krigbaum NY, Cohn BA.
    Am J Obstet Gynecol; 2022 Jan; 226(1):132.e1-132.e14. PubMed ID: 34767803
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Two-year follow-up of a randomised trial with repeated antenatal betamethasone.
    Peltoniemi OM, Kari MA, Lano A, Yliherva A, Puosi R, Lehtonen L, Tammela O, Hallman M, Repeat Antenatal Betamethasone (RepeatBM) Follow-Up Study Group.
    Arch Dis Child Fetal Neonatal Ed; 2009 Nov; 94(6):F402-6. PubMed ID: 19531521
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.